Wed, Apr 16, 2014, 1:27 AM EDT - U.S. Markets open in 8 hrs 3 mins

Recent

% | $
Quotes you view appear here for quick access.

Sarepta Therapeutics, Inc. Message Board

  • madmoneyguru madmoneyguru Apr 15, 2013 6:35 PM Flag

    FDA asking for dystrophin because GSK's drug DOESN'T DO IT.

    The FDA is asking for dystrophin as a surrogate endpoing, because the GSK drug doesn't do it and this will directly support AA and rapid approval of eteplirsen. Faster than anybody expects. Watch it happen in 2013.

 
SRPT
22.67+0.38(+1.70%)Apr 15 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.